iSpecimen Inc. offers an online marketplace for human biospecimens, connecting life scientists in commercial and non-profit organizations with healthcare providers which have access to patients and specimens needed for medical discovery. iSpecimen Inc. is based in LEXINGTON, Mass.
| Revenue (Most Recent Fiscal Year) | $9.29M |
| Net Income (Most Recent Fiscal Year) | $-12.50M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 1.33 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 1.45 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -343.86% |
| Net Margin (Trailing 12 Months) | -343.86% |
| Return on Equity (Trailing 12 Months) | -531.78% |
| Return on Assets (Trailing 12 Months) | -147.74% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.63 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.63 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | -- |
| Book Value per Share (Most Recent Fiscal Quarter) | $1.95 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $-7.89 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Common Shares Outstanding | 9.77M |
| Free Float | 8.58M |
| Market Capitalization | $4.45M |
| Average Volume (Last 20 Days) | 0.43M |
| Beta (Past 60 Months) | 1.80 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 12.20% |
| Percentage Held By Institutions (Latest 13F Reports) | 13.62% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |